EUVIMEDEUVIMED entdecken
Open Access

Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel

Mayan Gilboa, Tal Gonen, Noam Barda, Shelly Cohn, Victoria Indenbaum, Yael Weiss-Ottolenghi, Sharon Amit, Keren Asraf, Gili Joseph, Tal Levin, Yara Kanaaneh, Alex Aydenzon und 8 weitere

JAMA Network Open · 23.05.2023 · 6 (5) · e2314757

DOI: 10.1001/jamanetworkopen.2023.14757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 23.05.2023. Verfasst von Mayan Gilboa und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Sheba Pandemic Preparedness Research Institute, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance A correlation between antibody levels and risk of infection has been demonstrated for the wild-type, Alpha, and Delta SARS-COV-2 variants. High rates of breakthrough infections by the Omicron variant emphasized the need to investigate whether the humoral response elicited by mRNA vaccines is also associated with reduced risk of Omicron infection and disease.

Objective

To investigate whether the high antibody levels in individuals who have received at least 3 doses of an mRNA vaccine are associated with reduced risk of Omicron infection and disease. Design, Setting, and Participants This prospective cohort study used serial real time–polymerase chain reaction (RT-PCR) and serological test data from January and May 2022 to assess the association of preinfection immunoglobin G (IgG) and neutralizing antibody titers with incidence of Omicron variant infection, incidence of symptomatic disease, and infectivity. Participants included health care workers who had received 3 or 4 doses of an mRNA COVID-19 vaccine. Data were analyzed from May to August 2022. Exposures Levels of SARS-CoV-2 anti–receptor binding domain IgG and neutralizing antibodies. Main Outcomes and Measures The main outcomes were incidence of Omicron infection, incidence of symptomatic disease, and infectivity. Outcomes were measured using SARS-COV-2 PCR and antigen testing and daily online surveys regarding symptomatic disease.

Results

This study included 3 cohorts for 3 different analyses: 2310 participants were included in the protection from infection analysis (4689 exposure events; median [IQR] age, 50 [40-60] years; 3590 [76.6%] among female health care workers), 667 participants (median [IQR] age, 46.28 (37.44,54.8); 516 [77.4%] female) in the symptomatic disease analysis, and 532 participants (median [IQR] age, 48 [39-56] years; 403 [75.8%] female) in the infectivity analysis. Lower odds of infection were observed for each 10-fold increase in preinfection IgG (odds ratio [OR], 0.71; 95% CI, 0.56-0.90) and for each 2-fold increase in neutralizing antibody titers (OR, 0.89; 95% CI, 0.83-0.95). The odds of substantial symptomatic disease were reduced for each 10-fold increase in IgG levels (OR, 0.48; 95% CI, 0.29-0.78) and for each 2-fold increase in neutralizing antibodies levels (OR, 0.86; 95% CI, 0.76-0.96). Infectivity, assessed by mean cycle threshold value, was not significantly decreased with increasing IgG or neutralizing antibodies titers. Conclusions and Relevance In this cohort study of vaccinated health care workers, IgG and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansFemaleMiddle AgedMaleIsraelCOVID-19 VaccinesCohort StudiesProspective StudiesSARS-CoV-2Antibodies, NeutralizingHealth PersonnelImmunoglobulin G

Substanzen

COVID-19 VaccinesAntibodies, NeutralizingImmunoglobulin G

Autor:innen und Institutionen

  • The Sheba Pandemic Preparedness Research Institute, Sheba Medical Center, Ramat Gan, Israel.
  • The Infection Prevention & Control Unit, Sheba Medical Center, Ramat Gan, Israel.
  • Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • ARC Innovation Center, Sheba Medical Center, Ramat Gan, Israel.
  • Software and Information Systems Engineering, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
  • Department of Epidemiology, Biostatistics and Community Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.

Zitieren

APA

Gilboa, M., Gonen, T., Barda, N., Cohn, S., Indenbaum, V., Weiss-Ottolenghi, Y., Amit, S., Asraf, K., Joseph, G., Levin, T., Kanaaneh, Y., Aydenzon, A., Canetti, M., Freedman, L., Zuckerman, N., Mendelson, E., Doolman, R., Kreiss, Y., Regev-Yochay, G., & Lustig, Y. (2023). Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel. JAMA Network Open, 6(5), e2314757. https://doi.org/10.1001/jamanetworkopen.2023.14757

Vancouver

Gilboa M, Gonen T, Barda N, Cohn S, Indenbaum V, Weiss-Ottolenghi Y, et al. Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel. JAMA Network Open. 2023;6(5):e2314757. doi:10.1001/jamanetworkopen.2023.14757

BibTeX
@article{Gilboa2023,
  author = {Gilboa, Mayan and Gonen, Tal and Barda, Noam and Cohn, Shelly and Indenbaum, Victoria and Weiss-Ottolenghi, Yael and Amit, Sharon and Asraf, Keren and Joseph, Gili and Levin, Tal and Kanaaneh, Yara and Aydenzon, Alex and Canetti, Michal and Freedman, Laurence and Zuckerman, Neta and Mendelson, Ella and Doolman, Ram and Kreiss, Yitshak and Regev-Yochay, Gili and Lustig, Yaniv},
  title = {Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {5},
  pages = {e2314757},
  doi = {10.1001/jamanetworkopen.2023.14757}
}
Kostenlos starten →